LBX Pharmacy Chain JSC
SSE:603883
P/B
Price to Book Value
Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.
Market Cap | P/B | ||||
---|---|---|---|---|---|
CN |
LBX Pharmacy Chain JSC
SSE:603883
|
20.9B CNY | 3.1 | ||
ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
74.6B Zac | 0 | |
ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
28.9B Zac | 0 | |
US |
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
15.6B USD | 1.2 | ||
BR |
Raia Drogasil SA
BOVESPA:RADL3
|
45.5B BRL | 7.6 | ||
CN |
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
46.6B CNY | 4.8 | ||
JP |
MatsukiyoCocokara & Co
TSE:3088
|
945B JPY | 1.9 | ||
SA |
Al Nahdi Medical Company SCJSC
SAU:4164
|
17.4B SAR | 7.1 | ||
MX |
Corporativo Fragua SAB de CV
BMV:FRAGUAB
|
77.3B MXN | 3.3 | ||
JP |
Cosmos Pharmaceutical Corp
TSE:3349
|
545.1B JPY | 2.5 | ||
CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
25.3B CNY | 3.7 |
P/B Forward Multiples
Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.